Eifrig's new Prosperity Investor pitches Seven "Forever" stocks and three "1,000% Winner" speculations -- and the Thinkolator has definite answers for six of those ten below, plus a few guesses at the others...

Monkeypox, progress against cancer... and yes, a little COVID-19 update ,too

This will be the thirteenth Doc Gumshoe pronouncement on the COVID-19 pandemic. Lucky or unlucky, I have no idea, but let’s get on with it. To the question “Where are we now?” the answer depends enormously on exactly where, geographically, we are. The differences in the new case and fatality rates in among the different […]

Doc Gumshoe on progress in vaccines, treatments and immunity

Herd Immunity, Masks, Vaccines and Therapeutics

Doc Gumshoe on "a few encouraging items"

Lots of quarterly updates, plus a deeper dive into Insurance and hospital investments as COVID-19 uncertainty reigns

We’re now a month past the “bottom” that the market hit on March 23 in the heat of the panic, and although the world is thinking about opening up now and throwing ever more “rescue” money from helicopters, we’re still not all that close to predicting when “back to normal” might hit… and just now […]

Doc Gumshoe on progress with Hydroxychloroquine, Remdesivir and other potential treatments... plus updates on heartburn treatments and Parkinson's Disease

Checking out the COVID-19 teaser from Technology Profits Confidential

What's being teased in the webinar ads for his Million Dollar Portfolio service?

Doc Gumshoe on COVID-19

Doc Gumshoe on opioids, FDA approvals, and, yes the Wuhan Coronavirus

Doc Gumshoe's updates on the Apple Watch, Physician Shortages, Ebola, Prostate Screenings and more

Doc Gumshoe looks at the state of cancer treatment... and some of the interesting drug approvals from 2018

Doc Gumshoe on Coffee vs. Energy Drinks, Opioid Tapering, Smallpox, Vaccinations, Lyme Disease, HIV and more...

What drugs hit in 2017? How did approvals compare to 2016?

What's Ernie Tremblay's CD19 AB4 Teaser All About?

What's the stock hinted at by Sid Riggs' Small-Cap Rocket Alert?

"The Shocking Surprise I Found in Trump's Personal Stock Portfolio" -- What's the "secretive, under-the rader company with a stranglehold on a super lucrative niche" hinted at by Chris Matthai?

Doc Gumshoe looks at progress in antivirals

[ed note: Michael Jorrin, who I dubbed “Doc Gumshoe,” is a longtime medical writer (not a doctor) who shares his thoughts with Gumshoe readers a couple times a month. He usually does not specifically cover investment ideas, and his words and opinions are his own — his past columns can be found here] Lots of […]

This pitch is not all that tough to decipher for those who are seasoned biotech investors, but it’s generating a lot of questions for us today so I thought we’d get a quick answer out for you — it’s certainly a stock that gets plenty of attention, so you won’t need much of a head […]

What's the $7 HCV Testing Stock Being teased by Ernie Tremblay's Biotech Insider Alert?

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. His bio, past articles, and most recent comments can be seen here. Enjoy!] OUT of the night that covers me, Black as the Pit from pole to pole, I thank […]

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]

[Ed Note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he sometimes mentions a couple publicly traded companies). His words and opinions are his own. […]

The New Metabolomics, Second in a Series

The New Metabolomics, First in a Series

Dharma Bummer to Pharma Stunner?

[ed note: Michael Jorrin is a longtime medical writer (not a doctor) who covers health and medical topics and trends for our readers, generally without an investment thesis. His words are his own, enjoy!] In the Doc Gumshoe blog about cancer that appeared in June of 2013 (you can check it out here), I commented […]

THE YEAR THAT WAS

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. His previous columns can be found here. Enjoy!] Every New Year, a friend and I flew to Boston. She’d gone to medical school […]

DR. KSS LOOKS AT A COMPANY TACKLING HEPATITIS B

Dr. KSS Looks at clotting for the Irregulars

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

Oh Yeah...It May Prevent Cancer, Too

Second of Two Parts

Here's to a "Green" Biotechnology Company....In A Manner of Speaking

Everything You Always Wanted to Know About HCV But Were Afraid to Ask

[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice.  As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]

Stocking stuffers and some brief comments from Doc Gumshoe